Chandler H. Park, MD

Expert oncologists offer closing thoughts on emerging therapeutic strategies, unmet needs, and the future of kidney cancer treatment.

Chandler H. Park, MD, discusses the role of support groups and outlines resources available to patients with kidney cancer.

An overview of the treatment protocol for patients with advanced RCC who are receiving IO/TKI or IO/IO combination therapy.

Genitourinary oncologists discuss the safety and efficacy of IO/TKI and IO/IO combination therapies in advanced renal cell carcinoma.

Expert perspectives on the decision-making process for selecting frontline systemic therapy for patients with advanced renal cell carcinoma.

A comprehensive overview of systemic therapies available for the treatment of patients with advanced renal cell carcinoma.

Experts in the field of kidney cancer discuss the risk stratification process for renal cell carcinoma and its effect on prognosis.

Clinical insights on the typical presentation of kidney cancer and the diagnostic process.

Chandler H. Park, MD, and Tian Zhang, MD, MHS, give an overview of renal cell carcinoma (RCC) and outline disease risk factors, symptoms, and prevention strategies.